| 注册
首页|期刊导航|浙江医学|齐拉西酮与奥氮平治疗精神分裂症的疗效和安全性Meta分析

齐拉西酮与奥氮平治疗精神分裂症的疗效和安全性Meta分析

孙云峰 应茵 夏仲尼

浙江医学Issue(3):208-212,221,6.
浙江医学Issue(3):208-212,221,6.

齐拉西酮与奥氮平治疗精神分裂症的疗效和安全性Meta分析

Efficacy and safety of ziprasidone and olanzapine in treatment of schizophrenia:a meta analysis

孙云峰 1应茵 1夏仲尼1

作者信息

  • 1. 310012 杭州,浙江省立同德医院药剂科
  • 折叠

摘要

Abstract

Objective To compare the efficacy and safety of ziprasidone with olanzapine in treatment of schizophrenia. Methods Nineteen studies were included and analyzed. The differences in efficiency, cure rate, scale score and adverse re-actions for treatment of schizophrenia between ziprasidone and olanzapine were evaluated. Results There were no differ-ences in efficiency, cure rate, scale score for treatment of schizophrenia between ziprasidone and olanzapine. The adverse re-actions of ziprasidone were mainly insomnia, extrapyramidal symptoms, abnormal electrocardiogram; and those of olanzapine were mainly lethargy, weight gain, increased appetite, increased blood sugar; the differences were statistical y significant. Conclusion Ziprasidone and olanzapine both are effective drugs for schizophrenia with a similar efficacy and different adverse reactions.

关键词

精神分裂症/齐拉西酮/奥氮平/疗效/安全性/Meta分析

Key words

Schizophrenia/Ziprasidone/Olanzapine/Efficacy Safety/Meta analysis

引用本文复制引用

孙云峰,应茵,夏仲尼..齐拉西酮与奥氮平治疗精神分裂症的疗效和安全性Meta分析[J].浙江医学,2014,(3):208-212,221,6.

基金项目

浙江省医学会临床科研基金项目 ()

浙江医学

OACSTPCD

1006-2785

访问量0
|
下载量0
段落导航相关论文